drugset
Drugs / Ad35-ENV
last change Feb 2016 re-read 3 minutes ago

Ad35-ENV

Vaccine

Developed for
HIV infectious disease
Investigated by
Beth Israel Deaconess Medical Center · HIV Vaccine Trials Network · International AIDS Vaccine Initiative · National Institute of Allergy and Infectious Diseases (NIAID) · Ragon Institute of MGH, MIT and Harvard

Trials 1

today NCT01215149 · Ph 1
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01215149 Oct 2010 → Dec 2012 HIV infectious disease International AIDS Vaccine Initiative Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Ad35.Env “adenovirus serotype 35 with an HIV-1 envelope A insert [Ad35.Env]” PMID 26833336 ↗ Feb 2016
1

NCT01215149 ↗
Modality Vaccine “Ad26-ENVA and Ad35-ENV HIV Vaccines” NCT01215149 ↗